324.69
Penumbra Inc stock is traded at $324.69, with a volume of 8,564.
It is up +0.33% in the last 24 hours and up +2.34% over the past month.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
See More
Previous Close:
$323.76
Open:
$323.87
24h Volume:
8,564
Relative Volume:
0.02
Market Cap:
$12.79B
Revenue:
$1.45B
Net Income/Loss:
$171.05M
P/E Ratio:
74.71
EPS:
4.3459
Net Cash Flow:
$212.73M
1W Performance:
-0.67%
1M Performance:
+2.34%
6M Performance:
-4.29%
1Y Performance:
+29.22%
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PEN
Penumbra Inc
|
324.68 | 12.87B | 1.45B | 171.05M | 212.73M | 4.3459 |
|
ABT
Abbott Laboratories
|
114.48 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.69 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.26 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.71 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.75 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Nov-18-25 | Initiated | Wells Fargo | Underweight |
| Oct-08-25 | Upgrade | Needham | Hold → Buy |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Trillium Asset Management LLC Acquires New Stake in Penumbra, Inc. $PEN - MarketBeat
BlackRock Inc. Invests $1.36 Billion in Penumbra, Inc. $PEN - MarketBeat
Incuvate Says Penumbra Infringed Blood Clot Detection System (1) - Bloomberg Law News
Penumbra, Inc. (NYSE:PEN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Penumbra (NYSE: PEN) grants president 3,060 RSUs with multi-year vesting - Stock Titan
Penumbra (PEN) Results at a Glance: Reported EPS Misses Expectations for This Review; Trading-Day Reaction: The Share Price Sheds 0.74% in the Available RecordForward Guidance Trends - Vinanet
NINE MASTS CAPITAL Ltd Acquires New Position in Penumbra, Inc. $PEN - MarketBeat
Citizens Financial Group Inc. RI Invests $9.88 Million in Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (PEN) Stock Analysis: Exploring a 10.65% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Fidelity Advisor Mid Cap II Fund's Penumbra Inc(PEN) Holding History - GuruFocus
Alberta Investment Management Corp Invests $10.46 Million in Penumbra, Inc. $PEN - MarketBeat
S&CO Inc. Takes Position in Penumbra, Inc. $PEN - MarketBeat
Technical Reactions to PEN Trends in Macro Strategies - Stock Traders Daily
Penumbra, Inc.: Financial Data Forecasts Estimates and Expectations | PEN | US70975L1070 - marketscreener.com
Barclays PLC (PEN) discloses 2.34M-share beneficial stake in Penumbra Inc - Stock Titan
Should Penumbra’s RED 68 Catheter Recall and Margin Strain Require Action From Penumbra (PEN) Investors? - webull.com
Penumbra, Inc. (PEN) stock price, news, quote and history - Yahoo Finance Singapore
Penumbra, Inc. (PEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Washington Trust Advisors, Inc.'s Penumbra Inc(PEN) Holding History - GuruFocus
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care - Nonstop Local News Montana
Penumbra, Inc. (PEN) Stock Analysis: Evaluating the 11.45% Potential Upside in Medical Devices - DirectorsTalk Interviews
Penumbra Inc (PEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bank of America Corp DE Sells 46,436 Shares of Penumbra, Inc. $PEN - MarketBeat
Royal Bank of Canada Decreases Holdings in Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc (PEN) Stock News Today - TradingKey
The Manufacturers Life Insurance Company Sells 65,658 Shares of Penumbra, Inc. $PEN - MarketBeat
THUNDER study demonstrates Penumbra's Thunderbolt CAVT system is safe and effective for stroke care - Med-Tech Insights
Penumbra, Inc. (PEN) Stock Forecasts - finance.yahoo.com
Penumbra Earnings: Thrombectomy and Embolization Markets Growing by Double Digits - Morningstar
Did Penumbra's (PEN) Voluntary RED 68 Catheter Recall Just Shift Its Investment Narrative? - simplywall.st
California State Teachers Retirement System Purchases 7,800 Shares of Penumbra, Inc. $PEN - MarketBeat
Sei Investments Co. Trims Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Amundi Buys 259,936 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra Stock Price Forecast. Should You Buy PEN? - StockInvest.us
Penumbra (NYSE:PEN) Posts Earnings Results, Misses Expectations By $0.27 EPS - MarketBeat
Penumbra Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Penumbra: Q2 Earnings Snapshot - marketscreener.com
Penumbra, Inc. Reports Second Quarter 2026 Financial Results - Barchart.com
Penumbra Inc earnings missed by $0.28, revenue topped estimates - Investing.com
Penumbra, Inc. Revenue Breakdown – NYSE:PEN - TradingView
85,000 Shares in Penumbra, Inc. $PEN Purchased by Empyrean Capital Partners LP - MarketBeat
Penumbra Releases Results of CAVT System Study for Stroke Patients - dicardiology.com
Penumbra Inc (PEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Penumbra Inc (PEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Penumbra Inc (PEN) Income Statement - TradingKey
Penumbra Inc (PEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Penumbra Inc (PEN) Cash Flow - TradingKey
Penumbra Inc (PEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Penumbra Inc (PEN) Institutional Confidence - TradingKey
PEN|Penumbra Inc|Price:318.730|Chg%:+0.760 - TradingKey
SummitTX Capital L.P. Acquires New Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):